CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 8,508	$ 6,714
General and administrative	3,225	3,103
Total operating expenses	11,733	9,817
Loss from operations	(11,733)	(9,817)
Interest expense	(87)	(89)
Other income, net	58	19
Net loss	(11,762)	(9,887)
Unrealized loss on available for sale securities	(509)
Comprehensive loss	$ (12,271)	$ (9,887)
Net loss per share, basic and diluted	$ (0.50)	$ (0.42)
Weighted-average shares of common stock outstanding, basic and diluted	23,492,295	23,283,658